Abstract:The von Hippel-Lindau tumor suppressor protein (pVHL) has emerged as a key factor in cellular responses to oxygen availability, being required for the oxygen-dependent proteolysis of alpha subunits of hypoxia inducible factor-1 (HIF). Mutations in VHL cause a hereditary cancer syndrome associated with dysregulated angiogenesis, and up-regulation of hypoxia inducible genes. Here we investigate the mechanisms underlying these processes and show that extracts from VHL-deficient renal carcinoma cells have a defect in HIF-alpha ubiquitylation activity which is complemented by exogenous pVHL. This defect was specific for HIF-alpha among a range of substrates tested. Furthermore, HIF-alpha subunits were the only pVHL-associated proteasomal substrates identified by comparison of metabolically labeled anti-pVHL immunoprecipitates from proteosomally inhibited cells and normal cells. Analysis of pVHL/HIF-alpha interactions defined short sequences of conserved residues within the internal transactivation domains of HIF-alpha molecules sufficient for recognition by pVHL. In contrast, while full-length pVHL and the p19 variant interact with HIF-alpha, the association was abrogated by further N-terminal and C-terminal truncations. The interaction was also disrupted by tumor-associated mutations in the beta-domain of pVHL and loss of interaction was associated with defective HIF-alpha ubiquitylation and regulation, defining a mechanism by which these mutations generate a constitutively hypoxic pattern of gene expression promoting angiogenesis. The findings indicate that pVHL regulates HIF-alpha proteolysis by acting as the recognition component of a ubiquitin ligase complex, and support a model in which its beta domain interacts with short recognition sequences in HIF-alpha subunits.

pVHL regulates protein stability of TCF/LEF transcription factor family via ubiquitin-independent proteasomal degradation

VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs

TET is targeted for proteasomal degradation by the PHD-pVHL pathway to reduce DNA hydroxymethylation

E3 Ubiquitin Ligase Vhl Regulates Hypoxia-Inducible Factor-1 Alpha To Maintain Regulatory T Cell Stability And Suppressive Capacity

TCTP Increases Stability of Hypoxia‐inducible Factor 1α by Interaction with and Degradation of the Tumour Suppressor VHL

Pvhl Negatively Regulates Antiviral Signaling by Targeting MAVS for Proteasomal Degradation.

Phosphorylation-dependent Cleavage Regulates Von Hippel Lindau Proteostasis and Function.

VBP1 negatively regulates CHIP and selectively inhibits the activity of hypoxia-inducible factor (HIF)-1α but not HIF-2α

Pvhl Acts As a Downstream Target of E2F1 to Suppress E2F1 Activity.

USP9X destabilizes pVHL and promotes cell proliferation.

WSB1 Promotes Tumor Metastasis by Inducing Pvhl Degradation

An Oxygen-Insensitive Hif-3α Isoform Inhibits Wnt Signaling by Destabilizing the Nuclear Β-Catenin Complex

VHL suppresses UBE3B-mediated breast tumor growth and metastasis

Β-Trcp Couples Β-Catenin Phosphorylation-Degradation and Regulates Xenopus Axis Formation

Ubiquitin/SUMO Modification Regulates VHL Protein Stability and Nucleocytoplasmic Localization.

Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma

HECT Domain-containing E3 Ubiquitin Ligase NEDD4L Negatively Regulates Wnt Signaling by Targeting Dishevelled for Proteasomal Degradation

Competition Between Two Phosphatases Fine-Tunes Hedgehog Signaling

SCF ubiquitin ligase regulates stability of von-Hippel Lindau protein and the HIF1α-dependent response to hypoxia

Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein

pVHL promotes lysosomal degradation of YAP in lung adenocarcinoma